Burn Injury Medications: Pain, Infection, and Scar Management Guide

James Wong — Founder & Pharmacist, LienScripts | March 26, 2026 | 8 min read

Burn injuries require multi-phase medication protocols spanning acute pain control, infection prevention, wound healing support, skin grafting recovery, and long-term scar management. This guide covers each medication phase and how a pharmacy lien captures the complete treatment record for demand packages.

Burn Injury Medications: Pain, Infection, and Scar Management Guide

Burn injury medication management encompasses four distinct treatment phases — acute pain control and infection prevention, wound healing support, skin graft recovery, and long-term scar management — each requiring different drug classes and each independently documenting the severity and duration of injury for the personal injury demand package. For attorneys handling burn cases, the pharmaceutical record is among the most comprehensive and persuasive forms of evidence because burn treatment is medication-intensive, multi-phase, and extends far longer than most other injury types.

• Acute phase medications include opioid analgesics (morphine, oxycodone, hydromorphone), topical antimicrobials (silver sulfadiazine, mafenide acetate), and anxiolytics for procedural pain management
• Infection prevention requires both topical and systemic antibiotics, with culture-guided therapy changes that document clinical decision-making
• Wound healing support involves nutritional supplements (zinc, vitamin C), antihistamines for healing itch (hydroxyzine, gabapentin), and sleep aids disrupted by pain and pruritus
• Scar management medications include prescription silicone gel, corticosteroid injections (triamcinolone), and laser preparation medications that continue for 12-24 months post-injury
• LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report documenting the full multi-phase burn medication record for demand packages

Acute Phase: Pain Control Is the First Priority

Burn pain is clinically recognized as among the most severe pain experiences in medicine. The World Health Organization's pain ladder is insufficient for serious burns — acute burn management typically requires aggressive multimodal analgesia from the outset. According to James Wong, PharmD, founder of LienScripts, "The volume and intensity of pain medications prescribed in the first two weeks of a burn case tells the adjuster more about injury severity than almost any other evidence category."

Acute burn pain medications:

• Oxycodone or hydromorphone — oral opioids for background pain management during the acute phase. Burn patients typically require higher and more frequent dosing than other injury types due to the severity of wound pain
• Morphine IV — used during inpatient burn care for patients with significant total body surface area (TBSA) involvement
• Ketamine — increasingly used as a sub-anesthetic procedural analgesic during dressing changes and debridement, reducing opioid requirements while providing dissociative pain relief
• Lorazepam or diazepam — short-course benzodiazepines prescribed specifically for procedural anxiety surrounding dressing changes, which are intensely painful and psychologically distressing

[!KEY] Burn dressing changes and wound debridement are among the most painful medical procedures, and the medications prescribed specifically for these procedures — procedural opioids, ketamine, benzodiazepines — are objective documentation of the treatment burden the patient endured. Each procedural medication fill corresponds to a wound care session.

Topical Antimicrobials: The Cost-Intensive Front Line

Destroyed skin barrier means constant infection risk. Topical antimicrobials applied directly to burn wounds are typically the highest-cost items in the acute burn pharmacy record:

• Silver sulfadiazine (Silvadene) 1% cream — broad-spectrum topical antimicrobial and the most widely used burn wound agent; applied at every dressing change, often consuming large quantities over weeks of treatment
• Mafenide acetate (Sulfamylon) — penetrates eschar and is preferred for deep burns, particularly full-thickness wounds and cartilaginous structures (ears, nose)
• Silver-impregnated dressings (Mepilex Ag, Aquacel Ag) — advanced prescription wound dressings providing sustained antimicrobial coverage; these represent significant per-unit prescription costs
• Mupirocin (Bactroban) — used for nasal decolonization and wound margin care in MRSA-positive patients

Systemic Antibiotics When Infection Develops

Wound infection and sepsis are leading causes of morbidity in burn patients. When clinical signs of infection emerge, systemic antibiotics are prescribed based on wound culture sensitivity:

• Piperacillin-tazobactam (Zosyn) — broad-spectrum coverage for polymicrobial wound infections
• Vancomycin — MRSA coverage, particularly common in patients with prolonged hospitalizations
• Fluconazole — antifungal coverage when wound cultures identify fungal colonization

Each antibiotic change documented in the pharmacy record reflects a culture-guided clinical decision, adding layers of objective evidence.

Wound Healing Phase: Itch, Sleep, and Nutrition

As burn wounds begin to close, the clinical focus shifts to managing the significant discomfort that accompanies healing and supporting the biological processes of tissue repair.

Pruritus (itch) management — a major quality-of-life issue:

• Hydroxyzine (Vistaril) — preferred for burn itch due to combined antihistamine and anxiolytic properties
• Gabapentin — increasingly recognized as effective for burn wound itch through its action on sensory nerve regeneration; also addresses emerging neuropathic pain
• Diphenhydramine — used primarily for nighttime itch management
• Doxepin — a low-dose tricyclic with potent antihistamine properties for refractory itch

[!TIP] Gabapentin prescribed during the wound healing phase of a burn case serves dual documentation purposes — it simultaneously documents neuropathic pain from nerve regeneration and the severity of healing-phase pruritus. Both symptoms are indicators of burn depth and tissue damage that support case valuation.

Nutritional and healing support:

• Vitamin C (ascorbic acid) 500-1000 mg — essential for collagen synthesis in wound repair
• Zinc sulfate 220 mg — supports immune function and wound healing
• Vitamin D — frequently depleted in burn patients; supplementation supports bone and tissue healing
• Protein supplementation — prescribed to meet the dramatically elevated metabolic demands of burn healing

Skin Grafting Recovery: Post-Surgical Medications

Patients with deep partial-thickness or full-thickness burns requiring skin grafting enter a surgical phase with its own medication needs:

• Post-operative opioids — harvest site pain (where donor skin is taken) is often reported as more painful than the burn wound itself
• Surgical prophylactic antibiotics — standard perioperative antibiotic coverage
• Anti-emetics — ondansetron or promethazine for post-anesthetic nausea
• Graft-site topical agents — specialized wound care products for both the graft site and the donor site

Long-Term Scar Management: 12-24 Months of Treatment

Hypertrophic scarring is nearly universal in partial-thickness and full-thickness burns. Scar management medications represent the longest phase of burn treatment and carry significant evidentiary weight because they document ongoing medical consequences well beyond the acute injury.

Scar management pharmacotherapy:

• Prescription silicone gel sheets and silicone gel — the standard of care for hypertrophic scar prevention and management; applied continuously for months
• Triamcinolone acetonide injections — intralesional corticosteroid injections for raised, rigid, or painful hypertrophic scars; administered in-office every 4-6 weeks
• 5-Fluorouracil (5-FU) injections — used for refractory keloid and hypertrophic scars, often in combination with triamcinolone
• Laser preparation medications — topical anesthetics (lidocaine cream) and post-procedure care medications for patients undergoing laser scar revision

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "The scar management phase is where many pharmacy records lose their power — patients stop filling prescriptions because they cannot afford months of silicone gel and repeated injection visits. A pharmacy lien keeps that treatment record continuous through the entire scar management timeline."

[!KEY] Scar management medications extending 12-24 months post-injury are among the most powerful evidence of lasting burn injury consequences. Each triamcinolone injection and silicone gel refill is a documented treatment for permanent disfigurement — a damages category that carries significant settlement value.

Psychological Medications: The Invisible Burn Injury

Depression, PTSD, body image disturbance, and anxiety are documented complications of serious burns. Pharmaceutical treatment for these conditions documents the psychological dimension of the burn injury:

• Sertraline or fluoxetine — SSRIs for depression and PTSD
• Prazosin — prescribed specifically for burn-related nightmares and PTSD-associated sleep disturbance
• Duloxetine — SNRI with dual benefit for neuropathic pain and depression

The Pharmacy Lien for Burn Cases

The LienScripts pharmacy lien covers every phase of burn treatment — from acute wound care agents through long-term scar management — at zero upfront cost. Enrolling at the acute phase ensures the complete multi-phase medication record is captured for the MERIT report and demand package.

Related Resources

• Burn Injury Medication Management in PI Cases
• Scar Treatment Medications and Pharmacy Liens
• Pain Management After an Accident
• Specialty Medications in Personal Injury
• What Is a MERIT Report?